In 2005, we published a paper in the Journal of Clinical Pathology describing a novel BRCA2 mutation in an Indonesian family detected using a novel rapid and sensitive BRCA1/2 mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing.1 In this paper, we described the method used in detail as there was, at that time, only a published abstract from the Groningen group to refer to as the original source.2 However, we did not realise that a contract signed by one of us some years earlier prohibited us from describing this method in detail before the developers of this technique had published it themselves. In the meantime, this has been realised.3 It was, therefore, unjustified for tables 1–4 to enclose such detail in our paper, for which we apologise to the Groningen group.
Footnotes
Competing interests: None declared.
References
- 1.Purnomosari D, Kartikawati D, Aryandono T.et al A novel BRCA2 mutation in an Indonesian family found with a novel rapid and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing. J Clin Pathol 200558493–499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.van der Hout A H, Mulder I M, Wu Y.et al A DGGE system for comprehensive mutation screening of the complete coding regions of BRCA1 and BRCA2 outside exons 11. Am J Hum Genet 1999652322 [Google Scholar]
- 3.van der Hout A H, van den Ouweland A M, van der Luijt R B.et al A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting. Hum Mutat 200627654–666. [DOI] [PubMed] [Google Scholar]